Dr. Nima Aghaebrahim, a neurointerventionalist at Baptist Health, explains why "time is brain" when treating a stroke. Then, ...

For stroke patients undergoing mechanical thrombectomy, adjunctive intra-arterial thrombolytics fell short for further ...

Countries committed to rolling out endovascular thrombectomy services are meeting with varying degrees of success.

Two new trials saw no impact of thrombolytics in reducing disability at 90 days, but some positive signals offer hope.

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a growing global reach.

With full enrollment completed, the company is one step closer to demonstrating the potential of the Aventus Thrombectomy System to revolutionize PE treatment. “This trial is a key step toward ...

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...